| COVID-19 Vaccine |
1 |
1 |
| Vaccines |
0 |
0.95 |
| Food and Drug Administration (FDA) |
0 |
0.67 |
| Patient Safety |
0 |
0.62 |
| Match |
0 |
0.57 |
| Adverse Effects |
0 |
0.28 |
| Immunization |
0 |
0.28 |
| Muscle |
0 |
0.28 |
| Influenza Vaccine |
0 |
0.24 |
| COVID-19 |
0 |
0.23 |
| Medical Life |
0 |
0.15 |
| Cholecystitis |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Europe |
0 |
0.14 |
| Fatigue |
0 |
0.14 |
| Gallbladder |
0 |
0.14 |
| Geriatrics |
0 |
0.14 |
| Kidney |
0 |
0.14 |
| Kidney, Ureter, and Bladder |
0 |
0.14 |
| Microbiology |
0 |
0.14 |
| Pain |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Peer Review |
0 |
0.14 |
| Severe Acute Respiratory Syndrome |
0 |
0.14 |
| Influenza |
0 |
0.07 |
| Biliary Disease |
0 |
0.06 |
| Renal Failure |
0 |
0.05 |
| Acute Respiratory Distress Syndrome |
0 |
0.04 |
| Headache |
0 |
0.04 |
| Microbiome |
0 |
0.04 |
| Pain Management |
0 |
0.04 |